Bioavailability assessment of hydroxymethylglutaryl coenzyme A reductase inhibitor utilizing pulsatile drug delivery system: a pilot study

References

• Ali J, Saigal N, Qureshi MJ, et al. (2010). Chronopharmaceutics: a promising drug delivery finding of the last two decades. Recent Pat Drug Deliv Formul 4:129–44
   PubMedGoogle Scholar
• Barakat NS, Al-Suwayeh SA, Taha EI, Bakry Yassin AE. (2011). A new pressure-controlled colon delivery capsule for chronotherapeutic treatment of nocturnal asthma. J Drug Targe 19:365–72
   PubMed Web of Science ®Google Scholar
• Bussemer T, Otto I, Bodmeier R. (2001). Pulsatile drug-delivery systems. Crit Rev Ther Drug Carrier Syst 18:433–58
   PubMed Web of Science ®Google Scholar
• Charman SA, Charman WN, Rogge MC, et al. (1992). Selfemulsifying drug delivery systems: formulation and biopharmaceutic evaluation of an investigational lipophilic compound. Pharm Res 9:87–93
   PubMed Web of Science ®Google Scholar
• Chourasia MK, Jain SK. (2003). Pharmaceuticxal approaches to colon targeted drug delivery systems. J Pharm Pharmaceut Sci 6:33–66
   PubMed Web of Science ®Google Scholar
• Cole ET, Scott RA, Connor AL, et al. (2002). Enteric coated HPMC capsules designed to achieve intestinal targeting. Int J Pharm 231:83–95
   PubMed Web of Science ®Google Scholar
• Dabhi C, Randale S, Belgamwar V, et al. (2010). Predictable pulsatile release of tramadol hydrochloride for chronotherapeutics of arthritis. Drug Deliv 17:273–81
   PubMed Web of Science ®Google Scholar
• De Oliveira HP, Albuquerque JJ Jr, Nogueiras C, Rieumont J. (2009). Physical chemistry behavior of enteric polymer in drug release systems. Int J Pharm 366:185–9
   PubMed Web of Science ®Google Scholar
• Ding MJ, Yuan LH, Li Y, et al. (2011). Pharmacokinetics and bioequivalence study of simvastatin orally disintegrating tablets in Chinese healthy volunteers by LC-ESI-MS/MS. J Bioequiv Availab 3:032–7
   Google Scholar
• Do TT, Van Speybroeck M, Mols R, et al. (2011). The conflict between in vitro release studies in human biorelevant media and the in vivo exposure in rats of the lipophilic compound fenofibrate. Int J Pharm 414:118–24
   PubMed Web of Science ®Google Scholar
• Ghimire M, McInnes FJ, Watson DG, et al. (2007). In-vitro/in-vivo correlation of pulsatile drug release from presscoated tablet formulations: a pharmacoscintigraphic study in the beagle dog. Eur J Pharm Biopharm 67:515–23
   PubMed Web of Science ®Google Scholar
• Humberstone A, Charman WN. (1997). Lipid-based vehicles for the oral delivery of poorly water soluble drugs. Adv Drug Deliv Rev 25:103–28
   Web of Science ®Google Scholar
• Huyghebaert N, Vermeire A, Remon JP. (2014). Alternative method for enteric coating of HPMC capsules resulting in ready-to-use enteric-coated capsules. Eur J Pharm Sci 21:617–23
   Web of Science ®Google Scholar
• Jang DJ, Kim ST, Lee K, Oh E. (2014). Improved bioavailability and antiasthmatic efficacy of poorly soluble curcumin-solid dispersion granules obtained using fluid bed granulation. Biomed Mater Eng 24:413–29
   PubMed Web of Science ®Google Scholar
• Kang BK, Lee JS, Chon SK, et al. (2004). Development of self-microemulsifying drug delivery systems (SMEDDS) for oral bioavailability enhancement of simvastatin in beagle dogs. Int J Pharm 274:65–73
   PubMed Web of Science ®Google Scholar
• Kopecka J, Campia I, Olivero P, et al. (2011). A LDL-masked liposomal-doxorubicin reverses drug resistance in human cancer cells. J Control Release 149:196–205
   PubMed Web of Science ®Google Scholar
• Liao JK. (2005). Clinical implications for statin pleiotropy. Curr Opin Lipidol 16:624–9
   PubMed Web of Science ®Google Scholar
• Mandal AS, Biswas N, Karim KM, et al. (2010). Drug delivery system based on chronobiology – a review. J Control Release 147:314–25
   PubMed Web of Science ®Google Scholar
• Mastiholimath VS, Dandagi PM, Jain SS, et al. (2007). Time and pH dependent colon specific, pulsatile delivery of theophylline for nocturnal asthma. Int J Pharm 328:49–56
   PubMed Web of Science ®Google Scholar
• Memvanga PB, Eloy P, Gaigneaux EM, Préat V. (2013). In vitro lipolysis and intestinal transport of β-arteether-loaded lipid-based drug delivery systems. Pharm Res 30:2694–705
   PubMed Web of Science ®Google Scholar
• Niwa K, Takaya T, Morimoto T, Takada K. (1995). Preparation and evaluation of a time-controlled release capsule made of ethylcellulose for colon delivery of drugs. J Drug Target 3:83–9
   PubMed Web of Science ®Google Scholar
• Porter CJ, Pouton CW, Cuine JF, Charman WN. (2008). Enhancing intestinal drug solubilisation using lipid-based delivery systems. Adv Drug Deliv Rev 60:673–91
   PubMed Web of Science ®Google Scholar
• Pouton CW. (2000). Lipid formulations for oral administration of drugs: non-emulsifying, self-emulsifying and ‘self-microemulsifying' drug delivery systems. Eur J Pharm Sci 11:S93–8
   PubMed Web of Science ®Google Scholar
• Pouton CW. (2006). Formulation of poorly water-soluble drugs for oral administration: physicochemical and physiological issues and the lipid formulation classification system. Eur J Pharm Sci 29:278–87
   PubMed Web of Science ®Google Scholar
• Pouton CW, Porter CJ. (2008). Formulation of lipid-based delivery systems for oral administration: materials, methods and strategies. Adv Drug Deliv Rev 60:625–37
   PubMed Web of Science ®Google Scholar
• Sarasija S, Stutie P. (2005). Chronotherapeutics: emerging role of biorhythms in optimizing drug therapy. Indian J Phrm Sci 67:135–40
   Google Scholar
• Shabana MF, Mishriki AA, Issac MS, Bakhoum SW. (2013). Do MDR1 and SLCO1B1 polymorphisms influence the therapeutic response to atorvastatin? A study on a cohort of Egyptian patients with hypercholesterolemia. Mol Diagn Ther 5:299–309
   Web of Science ®Google Scholar
• Smolensky MH, Peppas NA. (2007). Chronobiology, drug delivery, and chronotherapeutics. Adv Drug Deliv Rev 59:828–51
   PubMed Web of Science ®Google Scholar
• Soni ML, Namdeo KP, Jain SK, et al. (2011). pH-enzyme di-dependent chronotherapeutic drug delivery system of theophylline for nocturnal asthma. Chem Pharm Bull (Tokyo) 59:191–5
   PubMed Web of Science ®Google Scholar
• Stella VJ, Nti-Addae KW. (2007). Prodrug strategies to overcome poor water solubility. Adv Drug Deliv Rev 59:677–94
   PubMed Web of Science ®Google Scholar
• Taha EI, Al-Saidan S, Samy AM, Khan MA. (2004). Preparation and in vitro characterization of self-nanoemulsified drug delivery system (SNEDDS) of all-trans-retinol acetate. Int J Pharm 285:109–19
   PubMed Web of Science ®Google Scholar
• Taha EI, Ghorab DM, Zaghloul AA. (2007). Bioavailability assessment of vitamin A self nanoemulsified drug delivery systems in rats: a comparative study. Med Princ Pract 16:355–9
   PubMed Web of Science ®Google Scholar
• Takaya T, Ikeda C, Imagawa N, et al. (1995). Development of a colon delivery capsule and the pharmacological activity of recombinant human granulocyte colony-stimulating factor (rhGCSF) in beagle dogs. J Pharm Pharmacol 47:474–8
   PubMed Web of Science ®Google Scholar
• Tyagi VK, Singh D, Pathak K. (2013). Semisolid matrix-filled hard gelatin capsules for rapid dissolution of amlodipine besilate: development and assessment. J Adv Pharm Technol Res 4:42–9
   PubMedGoogle Scholar
• Ward S, Lloyd JM, Pandor A, et al. (2007). A systematic review and economic evaluation of statins for the prevention of coronary events. Health Technol Assess 11:1–178
   Web of Science ®Google Scholar
• Yassin AE, Aodah AH, Al-Suwayeh S, Taha EI. (2012). Theophylline colon specific tablets for chronotherapeutic treatment of nocturnal asthma. Pharm Dev Technol 17:712–18
   PubMed Web of Science ®Google Scholar
• Zhang Z, Bu H, Gao Z, et al. (2010). The characteristics and mechanism of simvastatin loaded lipid nanoparticles to increase oral bioavailability in rats. Int J Pharm 394:147–53
   PubMed Web of Science ®Google Scholar